Effect of dapagliflozin on left ventricular mass in patients with kidney failure receiving maintenance hemodialysis: Primary results from the DAPA-HD trial

29 August 2026 (15:45 - 15:55)
Organised by: Logo
Congress Presentation Part of: Cardiovascular pharmacotherapy in advanced kidney disease: efficacy, safety, and outcomes Renal Failure and Cardiovascular Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology